Skip to content
Catalyst

PapersPMID:36181264

The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.

Phytotherapy research2023The record ↗

findings
4
compound
1
endpoints
4
no difference found
1
PMID:36181264
  1. Finding, very limited evidencelowersC-reactive protein concentration
  2. Finding, very limited evidencelowersDiastolic blood pressure
  3. Finding, very limited evidencelowersInterleukin-6 concentration
  4. Finding, very limited evidenceno difference foundSystolic blood pressure
Study, every finding
meta-analysis
Population, every finding
patients with metabolic syndrome and related disorders; random-effects pooling of randomized clinical trials
  • “The findings indicated that green cardamom significantly decreased diastolic blood pressure (WMD: -0.91 mmHg, 95%CI; -1.19, -0.62), high-sensitivity C-reactive protein (WMD: -1.21 mg/L, 95%CI; -2.18, -0.24), interleukin 6 levels (WMD: -2.41 ng/L, 95%CI; -4.35, -0.47).”

What did not

Study record

Design
meta-analysis
Species
human
Population
Patients with metabolic syndrome and related disorders in randomized clinical trials of green cardamom (Elettaria cardamomum seeds); eight reports, 595 patients pooled (abstract only)
Participants
595
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
4